What is the appropriate workup for a patient with low immunoglobulin G (IgG) and low immunoglobulin M (IgM)?

Workup of Low IgG and Low IgM

When you encounter a patient with both low IgG and low IgM, immediately assess vaccine responses and B-cell counts to distinguish between Common Variable Immunodeficiency (CVID), transient hypogammaglobulinemia, and secondary causes—this distinction is critical because CVID carries significant morbidity and mortality risks including bronchiectasis, autoimmune complications, and malignancy. 1

Initial Confirmatory Testing

• Repeat immunoglobulin measurements at least one month apart to confirm persistence of low IgG and IgM, as transient hypogammaglobulinemia is common and does not require aggressive intervention 1
• Measure serum total protein and albumin levels to identify secondary hypogammaglobulinemia from protein loss (nephrotic syndrome, protein-losing enteropathy) 1
• Obtain complete IgA level to characterize the antibody deficiency pattern—normal or low IgA with low IgG/IgM points toward different diagnoses on the diagnostic algorithm 1

Functional Antibody Assessment

The cornerstone of distinguishing clinically significant immunodeficiency from benign hypogammaglobulinemia is assessing vaccine responses to both protein and polysaccharide antigens. 1

• Evaluate responses to protein antigens (tetanus, diphtheria) that you've already administered through routine vaccination 1
• Assess polysaccharide antibody responses using pneumococcal vaccine (Pneumovax-23 in patients >6 years):
  • For ages >6 years: protective response requires concentration >1.3 mg/mL for >70% of serotypes tested 1
  • Severe impairment defined as <2 serotypes achieving protective levels 1
  • Test 2-4 weeks post-vaccination for optimal assessment 1

B-Cell Quantification

• Measure B-cell counts and subsets by flow cytometry, particularly switched memory B cells (CD27+IgD-) 1
• Absent or very low B cells (<2%) suggests agammaglobulinemia or severe CVID 1
• Normal B-cell counts with poor function characterizes most CVID cases 1

Rule Out Secondary Causes

Secondary immunodeficiencies are 30 times more common than primary immunodeficiencies, so systematically exclude these first. 2

Medication Review

• Investigate current and recent medications including:
  • Corticosteroids (chronic use) 2
  • Anti-epileptics (phenytoin, carbamazepine, valproic acid) 1
  • Immunosuppressants, especially rituximab (anti-CD20) 1, 2
  • Sulfasalazine, gold, penicillamine, hydroxychloroquine, NSAIDs 1

Protein Loss Assessment

• 24-hour urine protein with urine protein electrophoresis to detect nephrotic syndrome or light chain myeloma 2
• Consider gastrointestinal evaluation if chronic diarrhea present (protein-losing enteropathy) 2

Lymphoproliferative Disorders

• Peripheral blood immunophenotyping to identify circulating B-cell clones 2
• Thoracoabdominal CT scan to evaluate for:
  • Thymoma (associated with Good syndrome) 1
  • Lymphoma or other malignancies 1
  • Splenomegaly or lymphadenopathy 1

Serum Protein Electrophoresis

• Check for monoclonal protein and rule out cryoglobulinemia causing false hypogammaglobulinemia 2

Diagnostic Algorithm Based on Pattern

According to the diagnostic table for antibody deficiencies 1:

If IgG Low, IgM Normal or Low, IgA Normal or Low:

• Normal vaccine responses + normal/low B cells = Unspecified or transient hypogammaglobulinemia (monitor over time) 1
• Impaired vaccine responses + normal/low B cells = CVID or possible transient hypogammaglobulinemia (requires close monitoring) 1

If IgG Low, IgM Normal or High, IgA Low:

• Normal vaccine responses + normal B cells = Hyper-IgM syndrome 1

If All Immunoglobulins Absent:

• Absent vaccine responses = Agammaglobulinemia or severe CVID (evaluate cellular immunity as this may represent combined immunodeficiency) 1

Consider Cellular Immunity Evaluation

When significant humoral impairment is observed (very low IgG and IgM), evaluate cellular immunity because this could represent a combined immunodeficiency with worse prognosis. 1

• Lymphocyte subset analysis (CD3, CD4, CD8, CD19, CD16/56) 1
• Consider if patient has history of opportunistic infections 1

Clinical Context Integration

• Age matters: In children, transient hypogammaglobulinemia of infancy is common and typically resolves 3
• Infection history: Recurrent sinopulmonary infections with encapsulated bacteria (Streptococcus pneumoniae, Haemophilus influenzae) strongly suggest functional antibody deficiency 1, 4
• Autoimmune manifestations: Presence of autoimmune cytopenias, inflammatory bowel disease, or granulomatous disease increases likelihood of CVID 4
• Family history: 20-25% of CVID/antibody deficiency patients have affected family members 1

Critical Pitfalls to Avoid

• Do not diagnose primary immunodeficiency on a single low immunoglobulin measurement—always confirm persistence 1
• Do not assume normal total immunoglobulins exclude antibody deficiency—functional assessment via vaccine responses is essential 3
• Do not overlook medication-induced hypogammaglobulinemia, which is often reversible with drug cessation 1, 2
• Do not delay evaluation of cellular immunity in severe hypogammaglobulinemia, as combined immunodeficiency requires different management 1

Prognosis and Monitoring

CVID carries substantial morbidity and mortality, with bronchiectasis (OR 5.22) and noninfectious complications (OR 7.95) independently predicting death. 4 Patients require:

• Long-term monitoring for bronchiectasis development (present in 46.8% of CVID patients) 4
• Surveillance for autoimmune complications (33.3% develop hematologic autoimmunity) 4
• Vigilance for malignancy and lymphoproliferative disorders 1
• In contrast, transient or secondary hypogammaglobulinemia typically has benign course if underlying cause addressed 5